Brighter AB (Publ) announced the launch and commercial availability of its Actiste® service, aiming to improve the quality of life for people living with diabetes in Qatar. The company's distributor in Qatar - Al Danah Medical Company - has placed an initial order for a small number of Actiste® devices, which will shortly be shipped to the country. The value of the order is not material but besides being the first Actiste® devices that will be offered to diabetes patients in Qatar, the shipment is also a part of validating the processes that Brighter has in place - all the way from the factory to the end user.

The company believes that the Actiste® solutions, registered to be used by adults with diabetes could also, in the future, create new opportunities and value for a broad group of stakeholders: relatives, healthcare providers, authorities and governments, insurance companies and employers, the pharmaceutical industry, clinical-research organizations, and academic organizations. However, to secure sales and future revenue, collaboration with key healthcare providers is essential. The company is also working closely with its distributor who, once validation of the product is done, will be able to take part in public procurement bids.